News

In this artist’s conception of the process, an automated deposition system places a new material onto a base material (purple beam, right) as the last sample that was made is analyzed and sent to the AI (green beams, brain, left). The AI tells the pulsed laser deposition machine what to do next (data cable, bottom).
Researchers harness AI for autonomous discovery and optimization of materials
Students gather at a poster session
Students acquire skills at Quantum Science Center
Rectangular box being lifted by a red pully system up the left side of the building
Researchers make ‘green’ floor to replace steel

Filter News

Area of Research

News Type

Date

News Topics

Media Contacts

Connect with ORNL

ORNL scientists developed a method that improves the accuracy of the CRISPR Cas9 gene editing tool used to modify microbes for renewable fuels and chemicals production. This research draws on the lab’s expertise in quantum biology, artificial intelligence and synthetic biology. Credit: Philip Gray/ORNL, U.S. Dept. of Energy

Scientists use quantum biology, AI to sharpen genome editing tool

Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.

Hilda Klasky

Klasky named senior member of ACM

Hilda Klasky, an R&D staff member in the Scalable Biomedical Modeling group at ORNL, has been selected as a senior member of the Association of Computing Machinery, or ACM.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

DOE scientists deploy creativity, speed to disrupt COVID-19

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.